Rifampicin–Liposomes for <i>Mycobacterium abscessus</i> Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation

Rifampicin–Liposomes for <i>Mycobacterium abscessus</i> Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation

Treatment of pulmonary infections caused by <i>Mycobacterium abscessus</i> are extremely difficult to treat, as this species is naturally resistant to many common antibiotics. Liposomes are vesicular nanocarriers suitable for hydrophilic and lipophilic drug loading, able to deliver drugs...

Full description

Bibliographic Details
Main Authors: Federica Rinaldi, Patrizia Nadia Hanieh, Simona Sennato, Federica De Santis, Jacopo Forte, Maurizio Fraziano, Stefano Casciardi, Carlotta Marianecci, Federico Bordi, Maria Carafa
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
liposomes
rifampicin
<i>Mycobacterium abscessus</i>
antibiotic resistance
Online Access:https://www.mdpi.com/1999-4923/13/7/1070

Internet

https://www.mdpi.com/1999-4923/13/7/1070

Similar Items